Smart Tear Sensors May Help Detect Shifts in Eye Health Over Time

Dry eye disease, glaucoma, and other ocular disorders are often monitored through intermittent office visits. This approach can miss day-to-day changes in symptoms and tear-film behavior. Tears contain chemical signals linked to ocular health and, in some cases, broader physiological status. Researchers have now outlined a framework for wearable tear-based sensors that could support more reliable long-term eye health monitoring.

The Terasaki Institute for Biomedical Innovation, with collaborators at UC San Diego and USC, has described design priorities for next-generation ocular sensors in a Nature Sensors perspective. The proposed approach focuses on the tear film as a dynamic biological interface, rather than treating tears only as a source of biomarkers. It emphasizes that blinking, evaporation, and fluid turnover can affect sensor readings during real-world wear.

The framework calls for matching each biological signal to an appropriate sensing frequency and device format. Signals such as pH and electrolytes may require different monitoring strategies than larger proteins or inflammatory markers. The authors also recommend combining chemical sensing with contextual data, including blink patterns and tear flow, to help distinguish true biological changes from normal tear-film fluctuations.

The perspective identifies four areas needed for clinical translation. These include the biological interface, device performance during routine wear, clinical validation, and user trust. It also describes smart contact lenses, punctal devices, and periocular patches as complementary formats for different monitoring needs.

Dry eye disease is identified as a natural first proving ground because it is closely tied to tear-film instability and symptom fluctuation. The authors also highlight glaucoma monitoring and metabolic tracking as possible applications. They note that progress will require longitudinal studies that compare tear-based measurements with established clinical measures.

“Tear film isn’t just a source of biomarkers; it’s a constantly moving physiological system. If a sensor doesn’t account for blinking, evaporation, and fluid turnover, it’s very easy to mistake normal tear-film behavior for a biological signal,” said Dr. Chia-Wei Liu, Postdoctoral Researcher at the Terasaki Institute for Biomedical Innovation.

“Our goal is to move the field past counting how many biomarkers a device can detect and toward asking whether the readings can actually be trusted over time. That means designing sensors and interpretation methods together, not as separate problems,” said Dr. Yangzhi Zhu, Principal Investigator and Assistant Professor at the Terasaki Institute.

Related Links
Terasaki Institute for Biomedical Innovation